{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:04:42Z","timestamp":1771509882241,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009886","name":"Regione Puglia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009886","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-37423-z","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:24:43Z","timestamp":1769595883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myo-Inositol modulates AKT signalling, mitochondrial protein expression and intracellular Ca\u00b2\u207adynamics in human dermal fibroblasts"],"prefix":"10.1038","volume":"16","author":[{"given":"Paola","family":"Zanfardino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Amati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Iacobellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Colella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-6033","authenticated-orcid":false,"given":"Vittoria","family":"Petruzzella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"37423_CR1","doi-asserted-by":"crossref","unstructured":"Monastra, G., Dinicola, S. & Unfer, V. Physiological and pathophysiological roles of inositols. in A Clinical Guide to Inositols 9\u201329Elsevier, (2023).","DOI":"10.1016\/B978-0-323-91673-8.00008-X"},{"key":"37423_CR2","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1469-8137.2011.03939.x","volume":"192","author":"GE Gillaspy","year":"2011","unstructured":"Gillaspy, G. E. The cellular language of myo- inositol signaling. New Phytol. 192, 823\u2013839 (2011).","journal-title":"New Phytol."},{"key":"37423_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/361315a0","volume":"361","author":"MJ Berridge","year":"1993","unstructured":"Berridge, M. J. Inositol trisphosphate and calcium signalling. Nature 361, 315\u2013325 (1993).","journal-title":"Nature"},{"key":"37423_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.physiol.67.040103.152647","volume":"67","author":"MJ Berridge","year":"2005","unstructured":"Berridge, M. J. Unlocking the secrets of cell signaling. Annu. Rev. Physiol. 67, 1\u201321 (2005).","journal-title":"Annu. Rev. Physiol."},{"key":"37423_CR5","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1242\/dev.137075","volume":"143","author":"JSL Yu","year":"2016","unstructured":"Yu, J. S. L. & Cui, W. Proliferation, survival and metabolism: the role of PI3K\/AKT\/mTOR signalling in pluripotency and cell fate determination. Development 143, 3050\u20133060 (2016).","journal-title":"Development"},{"key":"37423_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano, A. et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer. 22, 138 (2023).","journal-title":"Mol. Cancer"},{"key":"37423_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.14336\/AD.2021.0729","volume":"13","author":"X Xie","year":"2022","unstructured":"Xie, X., Shu, R., Yu, C., Fu, Z. & Li, Z. Mammalian AKT, the emerging roles on mitochondrial function in diseases. Aging Disease. 13, 157 (2022).","journal-title":"Aging Disease"},{"key":"37423_CR8","doi-asserted-by":"publisher","first-page":"117693512311942","DOI":"10.1177\/11769351231194273","volume":"22","author":"EA Fadhal","year":"2023","unstructured":"Fadhal, E. A. Comprehensive analysis of the PI3K\/AKT pathway: unveiling key proteins and therapeutic targets for cancer treatment. Cancer Inf. 22, 11769351231194273 (2023).","journal-title":"Cancer Inf."},{"key":"37423_CR9","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang, X., Liu, G., Guo, J. & Su, Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int. J. Biol. Sci. 14, 1483\u20131496 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"37423_CR10","doi-asserted-by":"publisher","first-page":"1549277","DOI":"10.3389\/fimmu.2025.1549277","volume":"16","author":"J Bhatt","year":"2025","unstructured":"Bhatt, J., Ghigo, A. & Hirsch, E. PI3K\/Akt in IPF: untangling fibrosis and charting therapies. Front. Immunol. 16, 1549277 (2025).","journal-title":"Front. Immunol."},{"key":"37423_CR11","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1093\/brain\/awab226","volume":"144","author":"J Van Lent","year":"2021","unstructured":"Van Lent, J. et al. Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction. Brain 144, 2471\u20132485 (2021).","journal-title":"Brain"},{"key":"37423_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/hmg\/ddac201","volume":"32","author":"P Zanfardino","year":"2023","unstructured":"Zanfardino, P. et al. Mitofusin 2 mutation drives cell proliferation in Charcot-Marie-Tooth 2A fibroblasts. Hum. Mol. Genet. 32, 333\u2013350 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"37423_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/hmg\/ddae008","volume":"33","author":"P Zanfardino","year":"2024","unstructured":"Zanfardino, P. et al. OPA1 mutation affects autophagy and triggers senescence in autosomal dominant optic atrophy plus fibroblasts. Hum. Mol. Genet. 33, 768\u2013786 (2024).","journal-title":"Hum. Mol. Genet."},{"key":"37423_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/biom15030433","volume":"15","author":"P Zanfardino","year":"2025","unstructured":"Zanfardino, P., Amati, A., Perrone, M. & Petruzzella, V. The balance of MFN2 and OPA1 in mitochondrial Dynamics, cellular Homeostasis, and disease. Biomolecules 15, 433 (2025).","journal-title":"Biomolecules"},{"key":"37423_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1089\/jmf.2022.K.0152","volume":"26","author":"X Hu","year":"2023","unstructured":"Hu, X., Yang, M., Li, X., Gong, Z. & Duan, J. Myo-Inositol attenuates renal interstitial fibrosis in obstructive nephropathy by inhibiting PI3K\/AKT activation. J. Med. Food. 26, 368\u2013378 (2023).","journal-title":"J. Med. Food"},{"key":"37423_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3109\/09513590.2011.650660","volume":"28","author":"V Unfer","year":"2012","unstructured":"Unfer, V., Carlomagno, G., Dante, G. & Facchinetti, F. Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials. Gynecol. Endocrinol. 28, 509\u2013515 (2012).","journal-title":"Gynecol. Endocrinol."},{"key":"37423_CR17","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1002\/fsn3.4267","volume":"12","author":"T Aghajani","year":"2024","unstructured":"Aghajani, T., Arefhosseini, S., Ebrahimi-Mameghani, M. & Safaralizadeh, R. The effect of myo\u2010inositol supplementation on AMPK \/ PI3K \/ AKT pathway and insulin resistance in patients with NAFLD. Food Sci. Nutr. 12, 7177\u20137185 (2024).","journal-title":"Food Sci. Nutr."},{"key":"37423_CR18","doi-asserted-by":"publisher","first-page":"e001989","DOI":"10.1136\/openhrt-2022-001989","volume":"9","author":"JJ DiNicolantonio","year":"2022","unstructured":"DiNicolantonio, J. J. & H O\u2019Keefe, J. Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes. Open. Heart. 9, e001989 (2022).","journal-title":"Open. Heart"},{"key":"37423_CR19","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz, V. et al. Inositol for polycystic ovary syndrome: A systematic review and Meta-analysis to inform the 2023 update of the international Evidence-based PCOS guidelines. J. Clin. Endocrinol. Metabolism. 109, 1630\u20131655 (2024).","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"37423_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1083\/jcb.200901127","volume":"184","author":"VM Gohil","year":"2009","unstructured":"Gohil, V. M. & Greenberg, M. L. Mitochondrial membrane biogenesis: phospholipids and proteins go hand in hand. J. Cell Biol. 184, 469\u2013472 (2009).","journal-title":"J. Cell Biol."},{"key":"37423_CR21","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.jbior.2023.101001","volume":"91","author":"SR Lourdes","year":"2024","unstructured":"Lourdes, S. R., Gurung, R., Giri, S., Mitchell, C. A. & McGrath, M. J. A new role for phosphoinositides in regulating mitochondrial dynamics. Adv. Biol. Regul. 91, 101001 (2024).","journal-title":"Adv. Biol. Regul."},{"key":"37423_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.15252\/embj.201593564","volume":"35","author":"AL Marat","year":"2016","unstructured":"Marat, A. L. & Haucke, V. Phosphatidylinositol 3-phosphates\u2014at the interface between cell signalling and membrane traffic. EMBO J. 35, 561\u2013579 (2016).","journal-title":"EMBO J."},{"key":"37423_CR23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41580-022-00490-x","volume":"23","author":"Y Posor","year":"2022","unstructured":"Posor, Y., Jang, W. & Haucke, V. Phosphoinositides as membrane organizers. Nat. Rev. Mol. Cell. Biol. 23, 797\u2013816 (2022).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"37423_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/febs.15127","volume":"287","author":"L Palamiuc","year":"2020","unstructured":"Palamiuc, L., Ravi, A. & Emerling, B. M. Phosphoinositides in autophagy: current roles and future insights. FEBS J. 287, 222\u2013238 (2020).","journal-title":"FEBS J."},{"key":"37423_CR25","doi-asserted-by":"publisher","first-page":"e70008","DOI":"10.1002\/jimd.70008","volume":"48","author":"F Rossignol","year":"2025","unstructured":"Rossignol, F., Lamari, F. & Mitchell, G. A. Phosphoinositide metabolism: Biochemistry, physiology and genetic disorders. J. Inher Metab. Disea. 48, e70008 (2025).","journal-title":"J. Inher Metab. Disea"},{"key":"37423_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cellsig.2010.10.025","volume":"23","author":"E Rosivatz","year":"2011","unstructured":"Rosivatz, E. & Woscholski, R. Removal or masking of phosphatidylinositol(4,5)bisphosphate from the outer mitochondrial membrane causes mitochondrial fragmentation. Cell. Signal. 23, 478\u2013486 (2011).","journal-title":"Cell. Signal."},{"key":"37423_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41467-019-08924-5","volume":"10","author":"CW Hsieh","year":"2019","unstructured":"Hsieh, C. W. & Yang, W. Y. Omegasome-proximal PtdIns(4,5)P2 couples F-actin mediated mitoaggregate disassembly with autophagosome formation during mitophagy. Nat. Commun. 10, 969 (2019).","journal-title":"Nat. Commun."},{"key":"37423_CR28","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1126\/science.aax6089","volume":"367","author":"S Nagashima","year":"2020","unstructured":"Nagashima, S. et al. Golgi-derived PI (4) P-containing vesicles drive late steps of mitochondrial division. Science 367, 1366\u20131371 (2020).","journal-title":"Science"},{"key":"37423_CR29","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1016\/j.molcel.2021.08.025","volume":"81","author":"CC Hsu","year":"2021","unstructured":"Hsu, C. C. et al. Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK. Mol. Cell. 81, 3803\u20133819e7 (2021).","journal-title":"Mol. Cell"},{"key":"37423_CR30","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","volume":"340","author":"JE Nestler","year":"1999","unstructured":"Nestler, J. E., Jakubowicz, D. J., Reamer, P., Gunn, R. D. & Allan, G. Ovulatory and metabolic effects of d- Chiro -Inositol in the polycystic ovary syndrome. N Engl. J. Med. 340, 1314\u20131320 (1999).","journal-title":"N Engl. J. Med."},{"key":"37423_CR31","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.3390\/nu12113379","volume":"12","author":"A Pani","year":"2020","unstructured":"Pani, A. et al. Inositol and Non-Alcoholic fatty liver disease: A systematic review on deficiencies and supplementation. Nutrients 12, 3379 (2020).","journal-title":"Nutrients"},{"key":"37423_CR32","doi-asserted-by":"publisher","first-page":"1475329","DOI":"10.3389\/fvets.2024.1475329","volume":"11","author":"A Jawad","year":"2024","unstructured":"Jawad, A. et al. Myo-inositol improves developmental competence and reduces oxidative stress in Porcine parthenogenetic embryos. Front. Vet. Sci. 11, 1475329 (2024).","journal-title":"Front. Vet. Sci."},{"key":"37423_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preghy.2017.07.001","volume":"10","author":"R D\u2019Oria","year":"2017","unstructured":"D\u2019Oria, R. et al. PKB\/Akt and MAPK\/ERK phosphorylation is highly induced by inositols: novel potential insights in endothelial dysfunction in preeclampsia. Pregnancy Hypertens. 10, 107\u2013112 (2017).","journal-title":"Pregnancy Hypertens."},{"key":"37423_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1203\/00006450-199402000-00002","volume":"35","author":"GT Berry","year":"1994","unstructured":"Berry, G. T., Prantner, J. E., States, B. & Yandrasitz, J. R. The effect of glucose and galactose toxicity on Myo-inositol transport and metabolism in human skin fibroblasts in culture. Pediatr. Res. 35, 141\u2013146 (1994).","journal-title":"Pediatr. Res."},{"key":"37423_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12920-021-01001-1","volume":"14","author":"B Berti","year":"2021","unstructured":"Berti, B. et al. Bi-allelic variants in MTMR5\/SBF1 cause Charcot-Marie-Tooth type 4B3 featuring mitochondrial dysfunction. BMC Med. Genomics. 14, 157 (2021).","journal-title":"BMC Med. Genomics"},{"key":"37423_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00018-025-05612-0","volume":"82","author":"NR Komilova","year":"2025","unstructured":"Komilova, N. R. et al. Charcot Marie tooth disease pathology is associated with mitochondrial dysfunction and lower glutathione production. Cell. Mol. Life Sci. 82, 72 (2025).","journal-title":"Cell. Mol. Life Sci."},{"key":"37423_CR37","doi-asserted-by":"publisher","first-page":"123995","DOI":"10.1016\/j.lfs.2025.123995","volume":"381","author":"P Zanfardino","year":"2025","unstructured":"Zanfardino, P. et al. Selective mitophagy activation and protein aggregate accumulation in MTMR5\/SBF1-deficient fibroblasts. Life Sci. 381, 123995 (2025).","journal-title":"Life Sci."},{"key":"37423_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12931-023-02421-6","volume":"24","author":"JM Li","year":"2023","unstructured":"Li, J. M. et al. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis. Respir Res. 24, 132 (2023).","journal-title":"Respir Res."},{"key":"37423_CR39","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1046\/j.1471-4159.2002.01041.x","volume":"82","author":"SK Fisher","year":"2002","unstructured":"Fisher, S. K., Novak, J. E. & Agranoff, B. W. Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J. Neurochem. 82, 736\u2013754 (2002).","journal-title":"J. Neurochem."},{"key":"37423_CR40","first-page":"733","volume":"25","author":"R Dolhofer","year":"1987","unstructured":"Dolhofer, R. & Weiland, O. H. Enzymatic assay of myo-inositol in serum. J. Clin. Chem. Clin. Biochem. 25, 733\u2013736 (1987).","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"37423_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1515\/bchm3.1990.371.2.909","volume":"371","author":"M Schmolke","year":"1990","unstructured":"Schmolke, M., Bornemann, A. & Guder, W. G. Polyol determination along the rat nephron. Biol. Chem. Hoppe Seyler. 371, 909\u2013916 (1990).","journal-title":"Biol. Chem. Hoppe Seyler"},{"key":"37423_CR42","first-page":"2390","volume":"25","author":"AK Kiani","year":"2021","unstructured":"Kiani, A. K. et al. From Myo-inositol to D-chiro-inositol molecular pathways. Eur. Rev. Med. Pharmacol. Sci. 25, 2390\u20132402 (2021).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"37423_CR43","first-page":"201","volume":"41","author":"P Zanfardino","year":"2022","unstructured":"Zanfardino, P., Amati, A., Petracca, E. A., Santorelli, F. M. & Petruzzella, V. Torin1 restores proliferation rate in Charcot-Marie-Tooth disease type 2A cells harbouring MFN2 (mitofusin 2) mutation. Acta Myol. 41, 201\u2013206 (2022).","journal-title":"Acta Myol"},{"key":"37423_CR44","doi-asserted-by":"publisher","first-page":"110675","DOI":"10.1016\/j.abb.2025.110675","volume":"775","author":"M Tolomeo","year":"2026","unstructured":"Tolomeo, M. et al. Altered dimerization of certain riboflavin transporter 2 mutants: a possible source of UPR, altered calcium signalling and mitochondrial derangements in RTD2. Arch. Biochem. Biophys. 775, 110675 (2026).","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37423-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:05:35Z","timestamp":1771506335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-37423-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["37423"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-37423-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"14 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed on human dermal fibroblasts provided by the Laboratory of Molecular Medicine for Neurodegenerative and Neuromuscular Diseases, IRCCS Fondazione Stella Maris, Pisa, Italy. Fibroblast collection was carried out at IRCCS Fondazione Stella Maris following written informed consent from the patient\u2019s parents, in accordance with institutional and national ethical guidelines and the Declaration of Helsinki. Tissue collection and use were approved by the Comitato Etico Pediatrico Regione Toscana, IRCCS Fondazione Stella Maris (approval number: CEP 102\/2020). All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of the study results and related data was obtained from the patient\u2019s parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6545"}}